Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFT2D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAMPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996578 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FBXO33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTN2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMED4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHACTR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSEN54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDEM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NREP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on